{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:54:11Z","timestamp":1789667651574,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jaad.2019.08.078","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T11:22:51Z","timestamp":1567768971000},"page":"222-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["The emerging utility of the cutaneous microbiome in the treatment of acne and atopic dermatitis"],"prefix":"10.1016","volume":"82","author":[{"given":"Taylor E.","family":"Woo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Sibley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2019.08.078_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.0022-202x.2001.00043.x","article-title":"Skin microflora and bacterial infections of the skin","volume":"6","author":"Chiller","year":"2001","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.078_bib2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1365-2133.2008.08437.x","article-title":"Skin microbiota: a source of disease or defence?","volume":"158","author":"Cogen","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2019.08.078_bib3","doi-asserted-by":"crossref","first-page":"613979","DOI":"10.1155\/2008\/613979","article-title":"Conceptualizing human microbiota: from multicelled organ to ecological community","volume":"2008","author":"Foxman","year":"2008","journal-title":"Interdiscip Perspect Infect Dis"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.078_bib4","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1172\/JCI28521","article-title":"Epidermal barrier formation and recovery in skin disorders","volume":"116","author":"Segre","year":"2006","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.078_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrmicro.2017.157","article-title":"The human skin microbiome","volume":"16","author":"Byrd","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"5931","key":"10.1016\/j.jaad.2019.08.078_bib6","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1171700","article-title":"Topographical and temporal diversity of the human skin microbiome","volume":"324","author":"Grice","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.078_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00005-018-0528-4","article-title":"Human microbiome: composition and role in inflammatory skin diseases","volume":"67","author":"Balato","year":"2018","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.078_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-018-0404-9","article-title":"Commensal microbiota modulate gene expression in the skin","volume":"6","author":"Meisel","year":"2018","journal-title":"Microbiome"},{"issue":"6212","key":"10.1016\/j.jaad.2019.08.078_bib9","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1126\/science.1260144","article-title":"Dialogue between skin microbiota and immunity","volume":"346","author":"Belkaid","year":"2014","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.078_bib10","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/jid.2011.417","article-title":"Skin microbiome: looking back to move forward","volume":"132","author":"Kong","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.08.078_bib11","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.131029.111","article-title":"Temporal shifts in the\u00a0skin\u00a0microbiome associated with disease flares and treatment in children with atopic dermatitis","volume":"22","author":"Kong","year":"2012","journal-title":"Genome Res"},{"issue":"10","key":"10.1016\/j.jaad.2019.08.078_bib12","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/bcp.13662","article-title":"A systematic literature review of the human skin microbiome as biomarker for dermatological drug development","volume":"84","author":"Niemeyer-van der Kolk","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.078_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.det.2017.02.002","article-title":"Public health burden and epidemiology of atopic dermatitis","volume":"35","author":"Silverberg","year":"2017","journal-title":"Dermatol Clin"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.078_bib14","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/jid.2008.88","article-title":"\u201cOutside-to-inside\u201d (and now back \u201coutside\u201d) pathogenic mechanisms in atopic dermatitis","volume":"128","author":"Elias","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"14","key":"10.1016\/j.jaad.2019.08.078_bib15","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMra1011040","article-title":"Filaggrin mutations associated with skin and allergic diseases","volume":"365","author":"Irvine","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.078_bib16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tim.2017.11.008","article-title":"Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship","volume":"26","author":"Geoghegan","year":"2018","journal-title":"Trends Microbiol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.078_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrmicro3161","article-title":"Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus","volume":"12","author":"Foster","year":"2014","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.078_bib18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1067\/mai.2001.117455","article-title":"Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin","volume":"108","author":"Cho","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.078_bib19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.chom.2017.10.006","article-title":"Staphylococcus aureus\u00a0epicutaneous exposure drives skin inflammation via IL-36-mediated T cell responses","volume":"22","author":"Liu","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jaad.2019.08.078_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000331887","article-title":"Can microbial superantigens influence atopic dermatitis flares?","volume":"96","author":"Alomar","year":"2012","journal-title":"Chem Immunol Allergy"},{"issue":"397","key":"10.1016\/j.jaad.2019.08.078_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aal4651","article-title":"Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis","volume":"9","author":"Byrd","year":"2017","journal-title":"Sci Transl Med"},{"issue":"378","key":"10.1016\/j.jaad.2019.08.078_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4680","article-title":"Antimicrobials from\u00a0human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis","volume":"9","author":"Nakatsuji","year":"2017","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.078_bib23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2340\/00015555-2896","article-title":"Propionibacterium acnes abundance correlates inversely with\u00a0Staphylococcus aureus: data from atopic dermatitis skin microbiome","volume":"98","author":"Francuzik","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.078_bib24","doi-asserted-by":"crossref","first-page":"e55380","DOI":"10.1371\/journal.pone.0055380","article-title":"Fermentation of Propionibacterium acnes, a commensal bacterium in the human skin microbiome, as skin probiotics against methicillin-resistant Staphylococcus aureus","volume":"8","author":"Shu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2019.08.078_bib25","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3389\/fmicb.2016.01230","article-title":"Staphylococcus aureus shifts toward commensalism in response to Corynebacterium species","volume":"7","author":"Ramsey","year":"2016","journal-title":"Front Microbiol"},{"issue":"11","key":"10.1016\/j.jaad.2019.08.078_bib26","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1099\/ijsem.0.001367","article-title":"The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov","volume":"66","author":"Scholz","year":"2016","journal-title":"Int J Syst Evol Microbiol"},{"key":"10.1016\/j.jaad.2019.08.078_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jdv.14374","article-title":"What is new in the pathophysiology of acne, an overview","volume":"31","author":"Dr\u00e9no","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.078_bib28","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jaad.2008.07.013","article-title":"Self-esteem and body satisfaction among late adolescents with acne: results from a population survey","volume":"59","author":"Dalgard","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2019.08.078_bib29","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/exd.13296","article-title":"Skin microbiome and acne vulgaris: Staphylococcus, a new actor in acne","volume":"26","author":"Dreno","year":"2017","journal-title":"Exp Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.078_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/pde.13261","article-title":"The preadolescent acne microbiome: a prospective, randomized, pilot study investigating characterization and effects of acne therapy","volume":"34","author":"Coughlin","year":"2017","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.078_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12864-016-2489-5","article-title":"Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis","volume":"17","author":"Christensen","year":"2016","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.078_bib32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00253-013-5394-8","article-title":"Staphylococcus epidermidis in the\u00a0human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris","volume":"98","author":"Wang","year":"2014","journal-title":"Appl Microb Biotechnol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.078_bib33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jid.2015.12.024","article-title":"Staphylococcal LTA-induced miR-143 inhibits Propionibacterium acnes-mediated inflammatory response in skin","volume":"136","author":"Xia","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.078_bib34","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4103\/2229-5178.142483","article-title":"Side-effects of topical steroids: a long overdue revisit","volume":"5","author":"Coondoo","year":"2014","journal-title":"Indian Dermatol Online J"},{"issue":"8","key":"10.1016\/j.jaad.2019.08.078_bib35","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/jamadermatol.2017.1297","article-title":"Antibiotic resistance in acne treatment","volume":"153","author":"Adler","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.078_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2230.2004.01679.x","article-title":"Staphylococcus aureus re-colonization in atopic dermatitis: beyond the skin","volume":"30","author":"Gilani","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2019.08.078_bib37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41522-018-0077-y","article-title":"Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations","volume":"5","author":"Layeghifard","year":"2019","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"9","key":"10.1016\/j.jaad.2019.08.078_bib38","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1468-3083.2006.01748.x","article-title":"Influence of narrow-band UVB phototherapy on cutaneous microbiota of children with atopic dermatitis","volume":"20","author":"Silva","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2-3","key":"10.1016\/j.jaad.2019.08.078_bib39","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3402\/ijch.v67i2-3.18282","article-title":"The effect of UVB radiation on skin microbiota in patients with atopic dermatitis and healthy controls","volume":"67","author":"Dotterud","year":"2008","journal-title":"Int J Circumpolar Health"},{"issue":"9","key":"10.1016\/j.jaad.2019.08.078_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.120608","article-title":"First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis","volume":"3","author":"Myles","year":"2018","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.078_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-017-2118-x","article-title":"Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease\u00a0severity and the microbiome: study protocol for a\u00a0randomized controlled trial (MAAS trial)","volume":"18","author":"Tott\u00e9","year":"2017","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.078_bib42","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.jid.2018.03.433","article-title":"Clinical improvement in atopic dermatitis following autologous application of microbiome therapy targeting staphylococcus aureus","volume":"138","author":"Nakatsuji","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.08.078_bib43","unstructured":"Gallo R. Targeted microbiome transplant in atopic dermatitis. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03151148. Accessed September 25, 2019."},{"issue":"3","key":"10.1016\/j.jaad.2019.08.078_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0151184","article-title":"The formulation\u00a0of bacteriophage in a semi solid preparation for\u00a0control of Propionibacterium acnes growth","volume":"11","author":"Brown","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.078_bib45","first-page":"137","article-title":"Increase of skin-ceramide levels in aged subjects following a short-term topical application of bacterial sphingomyelinase from Streptococcus thermophilus","volume":"21","author":"De Simone","year":"2017","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.078_bib46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12275-008-0179-y","article-title":"Antimicrobial activity of\u00a0enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect","volume":"47","author":"Kang","year":"2009","journal-title":"J Microbiol"},{"issue":"9","key":"10.1016\/j.jaad.2019.08.078_bib47","first-page":"868","article-title":"Inhibition of Propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius","volume":"5","author":"Bowe","year":"2006","journal-title":"J Drugs Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2019.08.078_bib48","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.fct.2005.08.008","article-title":"Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria","volume":"44","author":"Oh","year":"2006","journal-title":"Food Chem Toxicol"},{"issue":"8","key":"10.1016\/j.jaad.2019.08.078_bib49","first-page":"12","article-title":"Results of a phase 2 efficacy and safety study with SB204, an investigational topical nitric oxide-releasing drug for the treatment of acne vulgaris","volume":"9","author":"Baldwin","year":"2016","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2019.08.078_bib50","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jid.2018.05.032","article-title":"The anti-inflammatory activities of Propionibacterium acnes CAMP factor-targeted acne vaccines","volume":"138","author":"Wang","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2019.08.078_bib51","unstructured":"Taylor E. 2019. A study of the safety, engraftment, and action of multi-dosed NB01 in adults with moderate acne. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03709654. Accessed September 25, 2019."},{"issue":"7","key":"10.1016\/j.jaad.2019.08.078_bib52","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ajg.2014.133","article-title":"Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients","volume":"109","author":"Kelly","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2019.08.078_bib53","first-page":"1","article-title":"Association of systemic\u00a0antibiotic treatment of acne with skin microbiota characteristics","volume":"21287","author":"Chien","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.078_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13555-018-0275-9","article-title":"Propionibacterium (Cutibacterium) acnes bacteriophage therapy in acne: current evidence and\u00a0future perspectives","volume":"9","author":"Castillo","year":"2018","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219326866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219326866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:54:00Z","timestamp":1759272840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219326866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0190962219326866"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.08.078","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging utility of the cutaneous microbiome in the treatment of acne and atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.08.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}